gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of ILEUM

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cancer of ILEUM in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Auernhammer, CJ; Bartenstein, P; Cyran, CC; Geisler, J; Haug, AR; Ilhan, H; Koch, W; Spitzweg, C	1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of ILEUM

Article	Year
Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography. Molecular imaging, 2014, Volume: 13 Topics: Adult; Aged; Aged, 80 and over; Female; Heterocyclic Compounds; Humans; Ileal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Treatment Outcome	2014

Article

Year

Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography.

Molecular imaging, 2014, Volume: 13

Topics: Adult; Aged; Aged, 80 and over; Female; Heterocyclic Compounds; Humans; Ileal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Treatment Outcome

2014